News
Pfizer (PFE) stock and BioNTech (BNTX) stock in focus as FDA may not renew the authorization for their pediatric COVID shot. Read more here.
GSK and CureVac will together receive $740 million, as well as royalties on sales of COVID-19 vaccines in the US ...
Six months into Donald Trump’s second term, his administration is at war with the federal judiciary, evading court orders ...
Shortly after that, the CDC overhauled its vaccine recommendations in COVID, nixing its endorsement of the shots for pregnant women and healthy children. At the time, RFK Jr. said he “couldn’t be more ...
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
10hon MSN
The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.
10h
MONTCO Today on MSNWSJ: GSK to Receive $370M in CureVac-BioNTech Vaccine DisputeGlaxosmithkline, which has major operations in Montgomery County, is set to receive a major settlement, writes Anthony O. Goriainoff for the Wall Street ...
Summit Therapeutics, which has consistently been communicating quarterly results through investor calls in the past few years ...
The research, done in mice and in human cells, shows that a protein called STUB1 restrains the immune system’s elite ...
CDC shooting tied to anti-vaccine beliefs sparks warnings from staff, as leaders clash over the future of mRNA vaccines and ...
In 2008, Madeline "Kara" Neumann, age 11, died of diabetic ketoacidosis in Wisconsin. Her parents treated her symptoms with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results